FDA NDC Directory · JSON-LD · Markdown

Xofluza

NDC 50242-583 · HUMAN PRESCRIPTION DRUG · GRANULE, FOR SOLUTION

Generic nameBALOXAVIR MARBOXIL
Labeler / ManufacturerGenentech, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214410
Dosage form / routeGRANULE, FOR SOLUTION · ORAL
Active ingredientsBALOXAVIR MARBOXIL (40 mg/20mL)
Marketing started20181024
Package count1

External sources

Source: openFDA. Public-domain (CC0).